Vitamin D3 plays an integral role in calcium absorption and bone health
Supports healthy immune function
Supports healthy skin
Supports healthy cartilage and joints
Supports healthy vascular tone
Inhibits lipid peroxidation
For many people the principal source of Vitamin D is through exposure of the skin to sunlight. Cholecalciferol, also known as vitamin D3, is formed from 7- dehydrocholesterol in the skin after exposure to UV light. Unfortunately, due to risk of skin cancer, many individuals are limiting sunlight exposure or using liberal amounts of sun protective factors (SPF) in sun tanning lotions, both of which limit vitamin D production in the skin. In the body cholecalciferol is hydroxylated to calcifediol in the liver and then to calcitriol in the kidneys, which are the active forms of vitamin D. The active forms of vitamin D work with parathyroid hormone and calcitonin to regulate serum calcium and phosphorus concentrations.
Vitamin D deficiency causes increased parathyroid hormone activity, which acts to maintain serum calcium and phosphate concentrations, at the expense of skeletal calcium.
See "More Info" tab to read more...
Serving size: 1 capsule Number of servings per container: 90 Amounts per serving:
Vitamin D3 (cholecalciferol).......4000 IU
Inactive Ingredients: Rice flour, cellulose
Contraindications Vitamin D is contraindicated in those with hypercalcemia and in those with evidence of vitamin D toxicity.
Precautions Pregnant women and nursing mothers should avoid vitamin D supplemental intakes greater than U.S. RDA amounts of the vitamin unless higher amounts are prescribed by their physicians. The current U.S. RDA for vitamin D is 400 IU or 10 mcg daily.
Interactions Supplemental levels of vitamin D above the U.S. RDA should be used with caution in those on digoxin or any cardiac glycoside. Hypercalcemia in those on digoxin may precipitate cardiac arrhythmias. Use of thiazide and pharmacologic doses of vitamin D may cause hypercalcemia in some.
Toxicity Dosage of vitamin D up to 60 mcg (2,400 IU)/day in healthy individuals rarely causes adverse reactions. Chronic doses of 95 mcg (3,800 IU)/day or greater in healthy individuals may cause hypercalcemia. Symptoms of hypercalcemia include: nausea, vomiting, weakness, headache, somnolence, dry mouth, constipation, metallic taste, muscle pain, and bone pain. Late symptoms include: polyuria, polydypsia, anorexia, weight loss, nocturia, conjunctivitis, pancreatitis, photophobia, rhinorrhea, pruritis, hyperthermia, decreased libido, elevated BUN, albuminuria, hypercholesterolemia, elevated ALT (SGPT), and AST (SGOT), ectopic calcification, nephrocalcinosis, hypertension and cardiac arrhythmias.
Read customer questions and answers about Vitamin D on our blog.
Bone Health Various studies have found an association between low serum levels of vitamin D and joint disorders as well as decreased bone density. In addition, risk for progression of these disorders increased substantially with both low Vitamin D intake and decreased serum level of vitamin D. Some of the best results obtained in studies on bone health have used 700 - 800 IU vitamin D per day, which is considerably higher than the recommended 400IU per day. The best results were obtained when vitamin D was given along with calcium.
Immune and Anti-inflammatory Support One researcher described Vitamin D as a ?flexible? bi-directional immuno-modulator. The cytokines interleukin 1 (IL-1) and interleukin 2 (IL- 2) are regulated favorably under the influence of Vitamin D.
Healthy Skin Topical Vitamin D analogues have been shown to be effective in treatment of certain skin disorders. Vitamin D has antiproliferative activity on keratinocytes and stimulated epidermal cell differentiation.
Cardiovascular Support Epidemiological data indicates that a low vitamin D status is associated with vascular disorders. Clinical studies have demonstrated an inverse relationship between circulating vitamin D levels and plasma rennin activity. It should also be noted that Vitamin D has been shown to inhibit lipid peroxidation.
Warning: Consult your health care provider before
Keep out of reach of children. Keep tightly capped and store in a cool, dry place.
Amin S, La Valley MP, Simms RW, Felson DT. The role of vitamin D in corticosteroid-induced osteoporosis. A meta-analytic approach. Arthritis Rheum. 42:1740-1751, 1999.
Kyriakidou-Himonas M, Aloia JF, Yeh JK. Vitamin D supplementation in postmenopausal black women. J Clin Endocrinol Metab. 84(11):3988-3990. 1999.
Zamora SA, Rizzoli R, Belli DC, Slosman DO, Bonjour JP. Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab. 84(12):4541-4544, 1999.
Ashcroft DM, Po ALW, Williams HC, Griffiths CEM. Systemic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. Br Med J. 320:963-967, 2000.
De Luca HF, Zierold C. Mechanisms and functions of vitamin D. Nutr Rev. 56:S4-S10, 1998.
Mantell DJ, Owens PE, Bundred NJ, et al. 1alpha, 25-Dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo. Circ Res 87:214-220, 2000.
Manolagas SC, Provvedini DM, Tsoukas CD. Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 43:113-122, 1985.
Tsoukas CD, Watry D, Escobar SS, et al. Inhibition of interleukin-1 production by 1,25 dihydroxyvitamin D3. J Clin Endocrinol Metabolism. 69:127-133, 1989.
PDR for Nutritional Supplements. 1st Ed. Medical Economics/Thomson Healthcare. Pp. 498-505. 2001.
Natural Medicines Comprehensive Database. 3rd Ed. Therapeutic Research Faculty, Stockton CA. 1070-1073. 2000.